PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Internal Medicine, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.\', \'Hospital Pharmacy, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.\', \'Digitalis Rx BV, Amsterdam, The Netherlands.\', \'Department of Clinical Decision Support, Health Base Foundation, Houten, The Netherlands.\', \'Cardiology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bcp.14751
?:doi
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33507556
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
?:title
  • No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all